Navigation Links
RNL BIO, a South Korean adult stem cell firm, introduces its autologous stem cell therapeutics in Turkey to treat patients with various intractable diseases
Date:9/12/2012

SEOUL, South Korea, Sept. 13, 2012 /PRNewswire/ -- RNL Bio (www.rnl.co.kr) announced on Sep 11, 2012 that it signed the agreement with RST Biomedikal Sanayi A.S. (RST), a Turkish company, to license RNL Bio's stem cell technology. Turkey is the 6th country where RNL Bio's stem cell technology has entered. This is one of the major accomplishments that RNL BIO has long focused on establishing the so-called 'Stem Cell Silk Road' with South Korean stem cell technology to give hope to patients with intractable diseases in the world.

RST as a licensee will pay the $5 million fee upfront within 60 days from the agreement and will continue to pay the running royalty of 15% of the revenue, which could be up to $ 200 million. RST will benefit from the geographical advantages of Turkey where Western, Arabic and Oriental cultures are crossed. It plans to establish a GMP facility and invite patients from Europe and Middle East early next year.

Ilknur Erdemin, CEO of RST said, "We expect to improve public health and the quality of life in Turkey through stem cell therapy technology imported from RNL BIO in treating various intractable diseases.  We will also grow Turkey to one of the world's most renowned country in regards to medical tourism with RNL's stem cell technology in combination with Turkish World's Heritage." To begin with, RST will focus on the treatment of diabetic complications, autoimmune diseases, cerebral palsy, and degenerative arthritis with RNL's autologous adipose derived stem cell technology. Stem cell therapy has already been allowed by Turkish health authority since 2011. Turkey actively promotes the industry of regenerative medicine and makes a quick move to expand in related fields. 

Dr. Jeong-Chan Ra, president of RNL Stem Cell Technology Institute said, "This licensing deal will be a good opportunity to develop RNL's stem cell technology to be the world's standards and to fulfill my goal to make RNL BIO a company that will have treated and helped the most patients suffering from intractable diseases." He had a seminar introducing his stem cell studies to Turkish attendees from related fields and distinguished invitees one day prior to signing licensing agreement.

 

 

 


'/>"/>
SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
4. Marken Opens Branch Office In Seoul, South Korea
5. CarePoint Partners Expands Coverage in Southeast
6. CPhI South America 2012 Returns to Brazil with One of a Kind Pharma Event
7. Albemarle expands South Haven API production site
8. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
9. Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action In Southern District Of New York
10. South Carolinas Stop-Sale System Achieves Significant Results In Battle Against Meth
11. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... EU5 Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 ... ... Outlook to 2022", provides key market data on the EU5 Magnetic ... of US dollars, volume (in units) and average prices (USD) within ... The report also provides company shares and distribution shares ...
(Date:2/20/2017)... 2017 Taiwan Biophotonic Co. (tBPC), a medical ... signs sensing solutions, today announced the CE Marking and ... oximeter, the oCare TM Pro 100, which is a ... devices space.  tBPC,s Wrist Pulse Oximeter, the ... and reliable method to measure and record heart rate ...
(Date:2/20/2017)... TEMPE, Ariz. , Feb. 20, 2017 /PRNewswire/ ... to the medical device industry, announced today that ... Vention Medical,s Device Manufacturing Services business.  ... bolsters its position as a leading services provider ... MedPlast,s acquisition will further expand the company,s ...
Breaking Medicine Technology:
(Date:2/20/2017)... ALEXANDRIA, VA (PRWEB) , ... February 20, 2017 , ... ... with Cambridge Healthcare to open and operate a state-of-the-art memory care community in Alexandria, ... of 2018 on a site just outside of Old Town. , The three-story ...
(Date:2/20/2017)... ... 2017 , ... Researchers at the University of Pittsburgh School of Medicine have ... may predict response to a particular class of drugs, not just in patients with ... new findings were published in Proceedings of the National Academy of Science. , “These ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, Biscom , the ... the first IoT device from Biscom designed to deliver confidential patient information securely ... at HIMSS17 and will be conducting demonstrations at Booth #374. ...
(Date:2/20/2017)... ... ... a Population Health Software Company, is pleased to announce a move to a larger office ... the size of the previous location while bringing life back to a medical practice building ... are excited to expand our footprint to better serve our growing client base. We ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and Center ... a joint event at Chuck E. Cheese’s locations throughout New England, New York and ... the opportunity to experience the fun of visiting Chuck E. Cheese’s in a sensory-friendly ...
Breaking Medicine News(10 mins):